Image source: The Motley Fool.
Eagle Pharmaceuticals (NASDAQ: EGRX)
Q2 2022 Earnings Call
Aug 09, 2022 , 8:30 a.m. ET
Operator
For further details see:
Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
Eagle Pharmaceuticals (NASDAQ: EGRX)
Q2 2022 Earnings Call
Aug 09, 2022 , 8:30 a.m. ET
Operator
For further details see:
Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
Market:
Eagle Pharmaceuticals Inc. Website:
WOODCLIFF LAKE, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that data from the Company’s Phase III trial demonstrating the sustained response of amisulpride for the rescue tr...
WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...